Novo Nordisk BV
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).
Novo Nordisk B.V.
Flemingweg 18, 2408 AV Alphen aan den Rijn
T: +31-172 44 94 94